Detalles de la búsqueda
1.
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion.
Future Oncol
; 17(34): 4697-4709, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581197
2.
Estimating Long-Term Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor Therapy: A Comparison of Standard and Mixture Cure Models.
Med Decis Making
; 39(3): 294-298, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30819038
3.
Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States.
J Med Econ
; 21(12): 1238-1245, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30260711
4.
Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.
Am J Clin Oncol
; 41(1): 65-72, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26398184
Resultados
1 -
4
de 4
1
Próxima >
>>